Psoriasis and HIV Infection
Actas Dermo-Sifiliográficas (English Edition), ISSN: 1578-2190, Vol: 99, Issue: 10, Page: 753-763
2008
- 20Citations
- 43Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Dermatologists face diagnostic and therapeutic difficulties when psoriasis coexists with human immunodeficiency virus (HIV) infection. This article will review some of the aspects of this coexistence from the epidemiologic, pathogenic, histopathologic, clinical, and prognostic point of view. The main skin diseases that should be included in the differential diagnosis are described. Also analyzed are the different therapeutic options in these patients according to the degree of immunodeficiency. Possibilities include antiretroviral treatment, topical treatment, retinoids, and classic immunosuppressants. The review will also cover current literature on the use of new biologic therapies in patients with HIV infection. Finally, we will discuss the risk of drug interactions during psoriasis treatment in these patients, who receive multiple pharmacologic therapies. La coexistencia de psoriasis con la infección por el virus de la inmunodeficiencia humana (VIH) implica dificultades diagnósticas y terapéuticas para el especialista en Dermatología. En este artículo se revisan las peculiaridades de dicha coexistencia desde el punto de vista epidemiológico, patogénico, anatomopatológico, clínico y pronóstico. Se describen las principales dermatosis que se incluyen en el diagnóstico diferencial. También se analizan las diferentes posibilidades terapéuticas en estos pacientes, dependiendo del grado de inmunosupresión. Se incluyen como opción de tratamiento la terapia antirretroviral, el tratamiento tópico, los retinoides, los fármacos inmunosupresores clásicos y se revisa la literatura actual sobre el uso de las nuevas terapias biológicas en pacientes con infección por el VIH. Finalmente, se describe el riesgo de interacciones farmacológicas que tienen lugar en el tratamiento de la psoriasis en estos pacientes, que reciben múltiples fármacos.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1578219008703639; http://dx.doi.org/10.1016/s1578-2190(08)70363-9; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=59849096334&origin=inward; http://linkinghub.elsevier.com/retrieve/pii/S1578219008703639; http://api.elsevier.com/content/article/PII:S1578219008703639?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1578219008703639?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S1578219008703639; http://dx.doi.org/10.1016/s1578-2190%2808%2970363-9; https://dx.doi.org/10.1016/s1578-2190%2808%2970363-9
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know